Skip to main content
. 2020 Mar 11;222(6):948–956. doi: 10.1093/infdis/jiaa099

Table 3.

Model-Based Reproduction Numbers, Immunity Thresholds for Eradication of Vaccine-Covered Oncogenic Human Papillomaviruses (HPVs), and Corresponding Critical Coverage of Vaccination by Vaccine Efficacy for Gender-Neutral (Girls and Boys) and Girls-Only (Girls) Vaccination Strategies

Reproduction Numbera Immunity Threshold Critical Coverage of Vaccination
VE 95% VE 80% VE 50%
HPV Type Girls and Boys Girls Girls and Boys Girls Girls and Boys Girls Girls and Boys Girls Girls and Boys Girls
HPV16 3.3 10 70% 90% 74% 95% 88% NEb NEb NEb
HPV18 2.2 4.5 55% 78% 58% 82% 69% 98% NEb NEb
HPV31/33 1.7 2.9 40% 65% 42% 68% 50% 81% 80% NEb
HPV45 1.7 2.9 40% 65% 42% 68% 50% 81% 80% NEb
HPV35 1.3 1.5 20% 35% 21% 37% 25% 44% 40% 70%

Abbreviations: NE, no eradication; VE, vaccine efficacy.

aReproduction number (R0) is calculated by determining the immunity threshold using the transmission model with a computational vaccine with 100% efficacy. In the gender-neutral vaccination strategy (girls and boys), R0 is from girls/boys to boys/girls. In the girls-only vaccination strategy (girls) R0 is from girls to girls (via boys, heterosexual model).

bNE = no eradication even with a 100% coverage of vaccination.